Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 1999 · 44 citations · 38 references
MedicineGeneticsHematologyHematopathologyHemostasisMedical GeneticsCoagulation DisordersDeep Vein ThrombosisHemostatic DisordersThromboembolic DiseaseThrombosisThrombotic DisordersAntithrombin FunctionGenetic ThrombophiliaPlasminogen ActivatorsProtein S FunctionThrombosis MechanismsThrombosis Pathophysiology
We systematically screened for the aetiology of thrombophilia in 115 patients with venous, arterial and small vessel thromboses. Forty-one patients (36% of those we examined) suffering from a variety of thromboses, including deep vein thrombosis, pulmonary embolism, arterial occlusion, cerebral infarction, Moyamoya disease and ulcerative colitis, were characterized either with positive lupus anticoagulants or with decreased activities of protein S, protein C, antithrombin III and/or plasminogen. Eight mutation sites were confirmed in 11 thrombotic patients using gene analysis. Decreased protein S activity was found with a high incidence (23 out of 115) in Japanese patients who suffered from not only venous thrombosis but also arterial and small vessel thrombosis. We emphasize here the important role of protein S in the pathogenesis of thrombosis in the Japanese population.
38
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Randall K. Saiki, David H. Gelfand, Susanne Stoffel et al. · Science · 1988 · 17.2K citations
Ted Koster, FR Rosendaal, Hans de Ronde et al. · The Lancet · 1993 · 1.3K citations
Medicine, Hematology, Hemostasis +14
World distribution of factor V Leiden
David C. Rees, Michael J. Cox, J. B. Clegg · The Lancet · 1995 · 1.2K citations